
    
      This is an observational cohort study collecting data and blood specimens at designated time
      points. The primary outcome will be comparing the cPRA in patients that have a rise in cf-DNA
      to those that do not have a rise in cf-DNA. Seondary outcomes include comparison of the
      combined incidence of need for transfusion, need for methylprednisolone and allograft
      nephrectomy, ESA dose, allograft tenderness, and gross hematuria.
    
  